Brief: Freeline Announces 2022 Corporate Priorities And Guidance

Freeline Therapeutics Holdings

13/12/2021 22:49

Dec 13 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE ANNOUNCES 2022 CORPORATE PRIORITIES AND GUIDANCE
    * FREELINE THERAPEUTICS HOLDINGS PLC - EXPECTS TO INCUR
CHARGES
RELATING TO ITS PROPOSED WORKFORCE REDUCTION BETWEEN $2.1 AND
$2.6 MILLION IN Q4 OF 2021
    * FREELINE THERAPEUTICS HOLDINGS PLC - DATA ANTICIPATED
ACROSS ALL
PROGRAMS BY MID-2022
    * FREELINE THERAPEUTICS HOLDINGS PLC - EXPECTS CURRENT LEVEL
OF
CASH AND CASH EQUIVALENTS WILL ENABLE CO TO FUND ITS OPERATING
EXPENSES INTO Q2 2023
    * FREELINE THERAPEUTICS HOLDINGS PLC - PROPOSED 25%
WORKFORCE
REDUCTION
    * FREELINE THERAPEUTICS HOLDINGS PLC - WORKFORCE REDUCTION
EXPECTED TO RESULT IN $1.3 MILLION TO $1.6 MILLION OF CASH
EXPENDITURES IN Q1 OF 2022
    * FREELINE THERAPEUTICS HOLDINGS PLC - WORKFORCE REDUCTION
EXPECTED TO RESULT IN $0.8 MILLION TO $1.0 MILLION OF CASH
EXPENDITURES IN Q2 OF 2022
    * FREELINE THERAPEUTICS - ESTIMATES PROPOSED REDUCTION IN
FORCE TO
DECREASE AGGREGATE CASH EXPENDITURES BY BETWEEN $4.7 MILLION AND
$5.1 MILLION IN 2022
    * FREELINE THERAPEUTICS - ESTIMATES PROPOSED REDUCTION IN
FORCE TO
DECREASE AGGREGATE CASH EXPENDITURES BY BETWEEN $7.0 MILLION AND
$7.6 MILLION IN 2023
    * FREELINE THERAPEUTICS - EXPECTS ITS CURRENT LEVEL OF CASH
AND
CASH EQUIVALENTS TO ENABLE CO TO FUND OPERATING EXPENSES INTO Q2
2023

Source text for Eikon:  ID:nGNX7G9TVm 
Further company coverage:  FRLN.O 

 ((Reuters.Briefs@thomsonreuters.com;))